INDIANAPOLIS , April 8, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its first-quarter 2020 financial results on Thursday, April 23, 2020 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial

INDIANAPOLIS , April 7, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) announced today that due to the public health impact of the coronavirus outbreak, and to support the health and well-being of its employees, shareholders, and other meeting participants, the Board of Directors of Eli

INDIANAPOLIS , March 9, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Barclays Global Healthcare Conference on Tuesday, March 10, 2020 . Ilya Yuffa , vice president, U.S. Diabetes, and Jeffrey Emmick , M.D., Ph.D., vice president, diabetes product development, will

INDIANAPOLIS , Feb. 21, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will participate in the Cowen and Company 40 th Annual Health Care Conference on Tuesday, March 3, 2020 . Joshua Smiley , senior vice president and Lilly 's chief financial officer, will participate in a fireside chat

INDIANAPOLIS , Feb. 21, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the 9th Annual SVB Leerink Global Healthcare Conference on Thursday, February 27, 2020 . Patrik Jonsson , Lilly senior vice president and president of Lilly Bio-Medicines, will participate in a

INDIANAPOLIS , Feb. 7, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Healthcare Talks Idea Forum on Thursday, February 13, 2020 . Jacob Van Naarden , chief operating officer for Loxo Oncology at Lilly; Eric Dozier , vice president, Lilly Oncology North

- Revenue in the fourth quarter of 2019 grew 8 percent, driven by 10 percent volume growth. Key growth products launched since 2014, including Trulicity, Taltz, Jardiance, Verzenio, Olumiant, Emgality, Basaglar, and Cyramza, contributed 14 percentage points of revenue growth and represented

INDIANAPOLIS , Jan. 16, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter and full-year 2019 financial results on Thursday, January 30, 2020 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the

INDIANAPOLIS , Jan. 2, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will participate in the 38 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020 . David A. Ricks , Lilly's chairman and chief executive officer, will participate in a fireside chat at 5:30 p.m.

- Lilly expects 2020 to be a strong year of financial and operational performance, characterized by robust top-line growth, margin expansion, continued pipeline progress and solid cash flow. - 2020 revenue is expected to be between $23.6 billion and $24.1 billion, driven by volume growth from key